OXYCURE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OXYCURE
Largest movements
- Tangible fixed assets -€542,552
down €542,552 (-7.7%), from €7.0m to €6.5m
of which Land and buildings: -€303,012
- Receivables within one year -€478,989
down €478,989 (-16.3%), from €2.9m to €2.5m
of which Trade receivables: -€479,014
- Debts after one year -€1.0m
down €1.0m (-16.4%), from €6.3m to €5.3m
- Current portion of long-term debt -€246,015
down €246,015 (-14.6%), from €1.7m to €1.4m
- Trade debts +€205,460
up €205,460 (+27.4%), from €749,783 to €955,243
- Depreciation -€473,496
down €473,496 (-15.2%), from €3.1m to €2.6m
- Turnover -€340,837
down €340,837 (-2.4%), from €14.2m to €13.8m
- Goods and materials -€227,694
down €227,694 (-28.4%), from €802,283 to €574,589
of which Purchases: -€135,906
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,332,932 | €11,215,786 | -€1.1m | -9.1% |
| Fixed assets | 21/28 | €7,776,641 | €7,111,150 | -€665,491 | -8.6% |
| Intangible fixed assets | 21 | €769,509 | €646,569 | -€122,939 | -16.0% |
| Tangible fixed assets | 22/27 | €7,003,852 | €6,461,301 | -€542,552 | -7.7% |
| Land and buildings | 22 | €2,822,216 | €2,519,203 | -€303,012 | -10.7% |
| Plant, machinery and equipment | 23 | €456,511 | €399,226 | -€57,284 | -12.5% |
| Furniture and vehicles | 24 | €193,898 | €128,772 | -€65,126 | -33.6% |
| Leasing and similar rights | 25 | €631,066 | €686,141 | +€55,076 | +8.7% |
| Other tangible fixed assets | 26 | €2,900,163 | €2,727,957 | -€172,206 | -5.9% |
| Financial fixed assets | 28 | €3,280 | €3,280 | = | 0.0% |
| Other financial fixed assets | 284/8 | €3,280 | €3,280 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €3,280 | €3,280 | = | 0.0% |
| Current assets | 29/58 | €4,556,291 | €4,104,636 | -€451,655 | -9.9% |
| Amounts receivable after more than one year | 29 | €10,000 | €14,000 | +€4,000 | +40.0% |
| Other amounts receivable | 291 | €10,000 | €14,000 | +€4,000 | +40.0% |
| Stocks and contracts in progress | 3 | €379,542 | €372,808 | -€6,733 | -1.8% |
| Stocks | 30/36 | €379,542 | €372,808 | -€6,733 | -1.8% |
| Goods purchased for resale | 34 | €379,542 | €372,808 | -€6,733 | -1.8% |
| Amounts receivable within one year | 40/41 | €2,932,339 | €2,453,350 | -€478,989 | -16.3% |
| Trade receivables | 40 | €2,931,063 | €2,452,049 | -€479,014 | -16.3% |
| Other amounts receivable | 41 | €1,277 | €1,301 | +€25 | +1.9% |
| Cash at bank and in hand | 54/58 | €1,060,837 | €1,041,753 | -€19,084 | -1.8% |
| Deferred charges and accrued income | 490/1 | €173,573 | €222,725 | +€49,152 | +28.3% |
| Total equity and liabilities | 10/49 | €12,332,932 | €11,215,786 | -€1.1m | -9.1% |
| Equity | 10/15 | €2,406,808 | €2,419,198 | +€12,390 | +0.5% |
| Contributions | 10/11 | €997,800 | €997,800 | = | 0.0% |
| Capital | 10 | €997,800 | €997,800 | = | 0.0% |
| Issued capital | 100 | €997,800 | €997,800 | = | 0.0% |
| Reserves | 13 | €99,780 | €99,780 | = | 0.0% |
| Non-distributable reserves | 130/1 | €99,780 | €99,780 | = | 0.0% |
| Legal reserve | 130 | €99,780 | €99,780 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,276,025 | €1,293,802 | +€17,778 | +1.4% |
| Investment grants | 15 | €33,204 | €27,816 | -€5,388 | -16.2% |
| Provisions and deferred taxes | 16 | €210,562 | €206,242 | -€4,320 | -2.1% |
| Provisions for liabilities and charges | 160/5 | €210,562 | €206,242 | -€4,320 | -2.1% |
| Other liabilities and charges | 164/5 | €210,562 | €206,242 | -€4,320 | -2.1% |
| Amounts payable | 17/49 | €9,715,562 | €8,590,347 | -€1.1m | -11.6% |
| Amounts payable after more than one year | 17 | €6,317,792 | €5,280,500 | -€1.0m | -16.4% |
| Financial debts | 170/4 | €6,317,792 | €5,280,500 | -€1.0m | -16.4% |
| Subordinated loans | 170 | €2,665,823 | €2,561,933 | -€103,890 | -3.9% |
| Leasing and similar obligations | 172 | €296,824 | €368,950 | +€72,126 | +24.3% |
| Credit institutions | 173 | €3,355,146 | €2,349,617 | -€1.0m | -30.0% |
| Amounts payable within one year | 42/48 | €3,350,087 | €3,309,197 | -€40,891 | -1.2% |
| Current portion of amounts payable after more than one year | 42 | €1,680,263 | €1,434,249 | -€246,015 | -14.6% |
| Trade debts | 44 | €749,783 | €955,243 | +€205,460 | +27.4% |
| Suppliers | 440/4 | €749,783 | €955,243 | +€205,460 | +27.4% |
| Taxes, remuneration and social security | 45 | €880,355 | €872,478 | -€7,877 | -0.9% |
| Taxes | 450/3 | €247,004 | €211,319 | -€35,685 | -14.4% |
| Remuneration and social security | 454/9 | €633,351 | €661,159 | +€27,809 | +4.4% |
| Other amounts payable | 47/48 | €39,687 | €47,227 | +€7,540 | +19.0% |
| Accrued charges and deferred income | 492/3 | €47,683 | €650 | -€47,032 | -98.6% |
| Operating income | 70/76A | €14,651,118 | €14,182,149 | -€468,969 | -3.2% |
| Turnover | 70 | €14,175,411 | €13,834,574 | -€340,837 | -2.4% |
| Other operating income | 74 | €313,055 | €347,575 | +€34,520 | +11.0% |
| Non-recurring operating income | 76A | €162,652 | - | -€162,652 | |
| Operating charges | 60/66A | €14,593,738 | €13,907,008 | -€686,730 | -4.7% |
| Goods for resale, raw materials and consumables | 60 | €802,283 | €574,589 | -€227,694 | -28.4% |
| Purchases | 600/8 | €703,762 | €567,856 | -€135,906 | -19.3% |
| Change in stocks: decrease (increase) | 609 | €98,521 | €6,733 | -€91,788 | -93.2% |
| Services and other goods | 61 | €6,251,092 | €6,225,130 | -€25,963 | -0.4% |
| Remuneration, social security and pensions | 62 | €4,336,984 | €4,365,783 | +€28,799 | +0.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,107,189 | €2,633,693 | -€473,496 | -15.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €8,484 | -€12,030 | -€20,515 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €11,530 | -€4,320 | -€15,850 | |
| Other operating charges | 640/8 | €71,519 | €74,350 | +€2,831 | +4.0% |
| Non-recurring operating charges | 66A | €4,656 | €49,813 | +€45,157 | +969.8% |
| Operating profit (loss) | 9901 | €57,380 | €275,141 | +€217,762 | +379.5% |
| Financial income | 75/76B | €2,803 | €5,390 | +€2,587 | +92.3% |
| Recurring financial income | 75 | €2,803 | €5,390 | +€2,587 | +92.3% |
| Income from current assets | 751 | - | €2 | +€2 | |
| Other financial income | 752/9 | €2,803 | €5,388 | +€2,585 | +92.2% |
| Financial charges | 65/66B | €247,867 | €262,753 | +€14,886 | +6.0% |
| Recurring financial charges | 65 | €247,867 | €262,753 | +€14,886 | +6.0% |
| Debt charges | 650 | - | €261,332 | +€261,332 | |
| Other financial charges | 652/9 | €247,867 | €1,421 | -€246,446 | -99.4% |
| Profit (loss) for the period before taxes | 9903 | -€187,685 | €17,778 | +€205,463 | |
| Income taxes | 67/77 | €70,547 | €1 | -€70,546 | -100.0% |
| Taxes | 670/3 | €70,547 | €1 | -€70,546 | -100.0% |
| Profit (loss) for the period | 9904 | -€258,232 | €17,778 | +€276,009 | |
| Profit (loss) for the period to be appropriated | 9905 | -€258,232 | €17,778 | +€276,009 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.